Federal grant · project grant (b)
Novel Methods to Improve Nuclease Mediated Homologous Recombination, Administrative Suppl - Project Abstract in This Administrative Supplement Grant Application, We Request Funds to Purchase a New Cell Sorter (S3E™ Cell Sorter, Bio-rad). This State of Art Cell Sorter Will Enable Us to Evaluate Large Size Gene Knock-in Events, Including Both On-target Knock-in, On-target Insertion/deletion (INDEL) Rates as Well as Potential Off-target Knock-in and Indel Events, at the Single Cell Resolution. in Aim 1, We Plan to Use This Cell Sorter to Evaluate MI-SPCAS9-V2. in Aim 2, We Will Use This Cell Sorter to Evalute MI-SACAS9. in Aim 3, We Will Use This Cell Sorter to Evaluate the Efficacy and Safety Profiles of MICAS9 in Clinically Relevant Applications. as a Results, This New Cell Sorter, Once Equipped, Will Generate More Convincing Data to Demonstrate the Advantages of the Proposed MICAS9 Gene Editing Nucleases.
Committed
$2.1 Million
Paid out
$2.0M
94%
Committed, not yet paid
$127.3K
6%
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then .
Loading…